[
  {
    "ts": null,
    "headline": "Top Stock Reports for Broadcom, Philip Morris & Novo Nordisk",
    "summary": "Broadcom, Philip Morris, and Novo Nordisk face contrasting outlooks as AI growth, smoke-free expansion, and obesity drug hurdles shape performance.",
    "url": "https://finnhub.io/api/news?id=2876b2cc6f0361ce9b45006c112562bea629cc75a7e115671ca57d687b6a9cfd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755117000,
      "headline": "Top Stock Reports for Broadcom, Philip Morris & Novo Nordisk",
      "id": 136344674,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "Broadcom, Philip Morris, and Novo Nordisk face contrasting outlooks as AI growth, smoke-free expansion, and obesity drug hurdles shape performance.",
      "url": "https://finnhub.io/api/news?id=2876b2cc6f0361ce9b45006c112562bea629cc75a7e115671ca57d687b6a9cfd"
    }
  },
  {
    "ts": null,
    "headline": "Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=75d19a5958c2a3597a6de0ec16d70d9b5f65a5368dca7d216914008f0c94144d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755092403,
      "headline": "Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term",
      "id": 136339921,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=75d19a5958c2a3597a6de0ec16d70d9b5f65a5368dca7d216914008f0c94144d"
    }
  },
  {
    "ts": null,
    "headline": "HCA Q2 Deep Dive: Diversified Portfolio and Policy Uncertainty Shape Outlook",
    "summary": "Hospital operator HCA Healthcare (NYSE:HCA) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 6.4% year on year to $18.61 billion. The company expects the full year’s revenue to be around $75 billion, close to analysts’ estimates. Its non-GAAP profit of $6.84 per share was 8.2% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=f5de29888077ea8acbf5bd85ad0a36fb85ea9591482fe0904fd841d41646f699",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755058728,
      "headline": "HCA Q2 Deep Dive: Diversified Portfolio and Policy Uncertainty Shape Outlook",
      "id": 136328534,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "Hospital operator HCA Healthcare (NYSE:HCA) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 6.4% year on year to $18.61 billion. The company expects the full year’s revenue to be around $75 billion, close to analysts’ estimates. Its non-GAAP profit of $6.84 per share was 8.2% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=f5de29888077ea8acbf5bd85ad0a36fb85ea9591482fe0904fd841d41646f699"
    }
  },
  {
    "ts": null,
    "headline": "5 Insightful Analyst Questions From HCA Healthcare’s Q2 Earnings Call",
    "summary": "HCA Healthcare’s second quarter results reflected steady demand for hospital services and a favorable payer mix, with management attributing performance to growth in high-acuity service lines like cardiac and neonatal care, as well as operational efficiencies across its local health networks. CEO Sam Hazen noted, “We had 14 out of 15 divisions that grew their admissions, and our cardiac procedure volume was up 5%.” The company also benefited from improved labor cost controls and a stable operati",
    "url": "https://finnhub.io/api/news?id=e71a5ebf095d59d172c77eaff398b77bf069482601cda1906605c9e4d187398d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755058206,
      "headline": "5 Insightful Analyst Questions From HCA Healthcare’s Q2 Earnings Call",
      "id": 136328535,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "HCA Healthcare’s second quarter results reflected steady demand for hospital services and a favorable payer mix, with management attributing performance to growth in high-acuity service lines like cardiac and neonatal care, as well as operational efficiencies across its local health networks. CEO Sam Hazen noted, “We had 14 out of 15 divisions that grew their admissions, and our cardiac procedure volume was up 5%.” The company also benefited from improved labor cost controls and a stable operati",
      "url": "https://finnhub.io/api/news?id=e71a5ebf095d59d172c77eaff398b77bf069482601cda1906605c9e4d187398d"
    }
  }
]